TECHWIRE 30
(CIX: WRAL30)  986.18    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: Apple)  524.94    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NY: QUINTILES)  50.22    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(OP: BASF SE)  110.32    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: BioCryst)  8.34    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: BioDelivery)  7.42    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: CEMP)  9.67    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: Cisco Systems)  23.21    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: Cornerstone)  9.49    (0 %)  Updated: 08:10 PM EST, Feb 03 2014
(NQ: Cree)  56.54    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: DARA)  2.55    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NY: EMC CORPORATION)  26.62    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(NQ: Extreme Networks)  5.67    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: Facebook)  58.94    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NY: GLAXOSMITHKLINE)  52.51    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(NQ: GOOG)  536.10    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NY: IBM)  190.01    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(NY: LH)  101.31    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(OP: Lenovo Group)  23.91    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NY: MRK)  56.47    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(NQ: Microsoft Corp)  40.01    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: NetApp)  35.87    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NY: NOVARTIS AG)  84.67    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(OP: Novozymes A/S)  44.76    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NY: PFIZER)  30.25    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(NQ: Pozen)  8.70    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NY: RED HAT)  50.55    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(NQ: BBRY)  7.15    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: Salix)  101.06    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: SQI)  26.05    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014

Posts tagged “BDSI”

May 10, 2010

Premium Lock BioDelivery Sciences wins Canadian approval for painkiller

BDSI The Raleigh-based firm can now sell its “breakthrough” pain killer drug outside of the U.S. It is seeking approval to sell Onsolis in Europe.

Updated April 20, 2010

Premium Lock BioDelivery Sciences stock plunges after $10M deal disclosed

BDSI The announced sale sends BDSI shares down 14 percent from Monday’s closing price of $4.21 per share.

September 2, 2009

Premium Lock BioDelivery Sciences closing lab in New Jersey, cutting five jobs

BDSI Chief science officer is also leaving drug development firm, which recently won FDA approval for its first product.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll